NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









IndyGeneUS Bio

IndyGeneUS Bio

Private
Baltimore, MarylandHealthcare & Life Scienceshttps://indygeneus.bio/

Last Round

Seed

Jan 12, 2026

Total Funding Raised

$2.28M

Company Overview

IndyGeneUS Bio is a biotechnology company that operates a clinico-genomic insight engine and a large, blockchain-encrypted bio-repository of African genomic data to advance drug discovery and precision health equity.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Infrastructure

Keywords

genomic databaseprecision medicinedrug discoverydiverse genomic dataclinical trialsbioinformaticsgenomicsdata as a serviceDaaSclinical researchwhole-genome sequencinggenomic AIbiotech datasovereign cloudAI-native biotechblockchain governancehealth equity

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

IndyGeneUS Bio Comparables

Compare IndyGeneUS Bio with similar companies based on industry and business-model similarity.

IndyGeneUS Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Syndicate Bio
86%
Yemaachi Biotechnology
77%
Variant Bio
73%

IndyGeneUS Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 12, 2026
GrantOct 25, 2024
AcceleratorDec 20, 2022
GrantMay 12, 2022
Pre SeedDec 27, 2021

IndyGeneUS Bio Investors

Notable investors and investment history

IndyGeneUS Bio investors
InvestorRounds
New Majority VenturesGrant
McKesson VenturesAccelerator
IsimoVest Venture Capital PartnersPre Seed
Northpond VenturesAccelerator
McKesson VenturesAccelerator
DownEast DigitalSeed
Northpond VenturesAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 3, 2026

    Monthly visitors increased 30% MoM, from 389 to 506.

IndyGeneUS Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

IndyGeneUS Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about IndyGeneUS Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersBaltimore, Maryland
Employee Range7
Year Founded2020
Last FundingJan 12, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.